Confidio Expands Investment in Innovation and Continues to Grow Team

Investing in top talent to develop sustainable and trusted solutions

[TOWSON, Maryland: April 1, 2021] – Confidio, a technology-enabled pharmacy benefits consulting firm, is expanding its focus on innovation to bring refreshed solutions to optimize the financial and clinical outcomes of prescription drug benefits for plan sponsors. Following six-months of expanding the team, Confidio has hired 19 new employees, including a strategic hire focused on strategic and innovative growth. This employee growth represents a 32 percent increase in employees since October 2020. Each of Confidio’s new hires, but specifically the newly developed Chief Innovation Officer role, is vital to achieving our strategic vision to bring new and enhanced solutions to market that support the evolving needs of a rapidly growing client portfolio.

Confidio is proud to welcome Todd Teixeira, Chief Innovation Officer, to the Confidio team.

Confidio’s strategic new hires include:

Todd Teixeira | ConfidioTodd N. Teixeira, MBA, Chief Innovation Officer

Todd is responsible for leading the ideation and strategy of our expanding portfolio of innovative solutions and services to further differentiate Confidio in the marketplace. Todd’s ownership of product development will strategically focus on the specific and unique needs of our clients, prospects, and channel partners. He is tasked with developing and deploying products and capabilities that drive lower pharmacy and medical costs, increase health outcomes, optimize the member experience, and provide actionable insights. Todd is an accomplished healthcare executive with more than 25 years of leadership experience in the pharmacy benefits industry. Todd has a widely recognized reputation for passionately cultivating high-performing, analytical, and consultative teams, as evidenced with prior Express Scripts Vice President roles in the areas of Account Management, Supply Chain Economics, and Payor Drug Pricing.

“Over the past several years, I couldn’t help but notice that the team at Confidio was building something special, challenging the industry, and creating tremendous value as advocates for patients and payors. The integrity and vision of the leadership team along with the collaborative culture permeating Confidio were particularly important to me. I am thrilled to help champion our healthcare mission and join such a talented, passionate, and entrepreneurially driven organization.” Teixeira said regarding his decision to join the Confidio team.

Additional new hires to the Confidio team include:

Jacque Abler – Account Coordinator
Annette Ainsleigh – Executive Assistant
Abraham Armenta – Associate Consultant
Diane Brake – VP, TPA Sales
Alicia Brown – Account Executive
Steve Cantrell – Account Manager
Ryan Cawley – VP of Finance
McKayla Hadean – Account Manager
Aubry Halloran – Salesforce Platform Manager
Taylor Hertel – Account Executive
Bridget Kraeuter – ISMS Manager
Karen Malhi – Sales Operations Specialist
Dawn McGuire – Account Coordinator
Amanda Pierce – Data Analytics Consultant
Jacquie Plaschko – Project Manager
Tom Price – Account Executive
Patrice Rubin – Account Manager
Curtis Wagner – Account Coordinator

“Our goal has always been to build an organization that attracts top talent from the managed pharmacy and healthcare industry. Our team continues to be a key differentiator and positions Confidio to be our clients’ most trusted consulting partner,” said Cory Easton, Co-Founder and Chief Sales Officer, as he reflected on Confidio’s continued growth.

“Confidio was built on bringing innovative solutions to the most complex issues facing the prescription drug benefit. We have taken a proactive approach to understanding our clients’ needs and industry trends, which we recognize requires an expanded focus on innovation to prepare for future challenges that will face our clients. By welcoming Todd to the team, we continue to invest in bringing the most innovative solutions possible to our clients,” said Scott Vogel, Co-Founder and CEO, on the organization’s recent expanded focus on innovation.

About Confidio: Confidio is a technology-enabled pharmacy benefits consulting firm. We optimize the value of your pharmacy benefits through transparency, accountability and advanced data analytics paired with deep insider expertise. We help you minimize drug spend while maximizing patient outcomes and satisfaction. Our reliable solutions are performance-based, results-driven and continuously validated.

Articles & Announcements

COVID Vaccine Update: Understanding Immunity and Potential for Boosters
FDA Approves Alzheimer’s Drug: Aduhelm
Confidio Expands Investment in Innovation and Continues to Grow Team
Important Changes in Healthcare Promoting Drug Price Transparency
COVID Vaccine Update
Breaking Down Barriers to Cancer Treatment: Problems and Solutions
Is your specialty drug management program only addressing half of your specialty spend?
The High Cost of Hemophilia A Treatments
Navigating HIV PrEP and the Affordable Care Act
Amazon launches “Amazon Pharmacy”, an online pharmacy store
The COVID Vaccine Derby: A Guide to the Top Contenders
Updated executive order on drug pricing, signed by President Trump
Confidio Hires 18 New Employees, Including 3 Strategic Executives
Are Brand-Name Drugs Safer Than Generics?
Understanding COVID-19’s Impact on pharmacy, the Economy and Our Future
President Trump’s Executive Orders on Drug Pricing
CONFIDIO Ranks No. 452 on the 2020 Inc. 5000 With Three-Year Revenue Growth of 1014.66%
Health Alert Updates: COVID-19
Emerging Treatments for Peanut Allergies
HHS Deploys Strategy to Import Drugs From Canada
White House reversal on Proposal to Eliminate Drug Rebates and Pushing Discounts to Point-of-Sale
BBJ’s Employee Benefits Administrators Listing
Will the Rebate Bubble Burst?
Valsartan Drug Recall Notice
Pharmacy Benefits 2020: Ready to Spend Half of Your Medical Plan Budget on Rx?
Pharmacy Predictions: 2019